Advisory Research Inc Halozyme Therapeutics, Inc. Transaction History

Advisory Research Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$40.06 - $59.44 $140,410 - $208,337	3,505 Added 9.24%	41,420 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $90,930 - $122,200	2,360 Added 6.64%	37,915 $1.5 Million
Q2 2022 Aug 17, 2022	BUY	$37.35 - $48.3 $1.33 Million - $1.72 Million	35,555 New	35,555 $1.57 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.